Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions
- PMID: 22480900
- DOI: 10.4088/JCP.10m06673
Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions
Abstract
Objective: To investigate the association between substance use disorders (SUDs) and the clinical presentation, risk factors, and correlates of major depressive disorder (MDD) by examining differences among 3 groups: (1) individuals with lifetime MDD and no comorbid SUD (MDD-NSUD); (2) individuals with comorbid MDD and SUD (MDD-SUD); and (3) individuals with substance-induced depressive disorder (SIDD).
Method: Data were derived from the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (N = 43,093). Diagnoses were made using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV Version.
Results: The lifetime prevalence of MDD-NSUD was 7.41%, whereas those of MDD-SUD and SIDD were 5.82% and 0.26%, respectively. Overall, risk factors for MDD were more common among individuals with MDD-SUD and SIDD than among those with MDD-NSUD. Individuals with MDD-SUD and SIDD had similar rates of comorbidity with any psychiatric disorder, but both groups had higher rates than individuals with MDD-NSUD (odds ratio [OR] = 2.3; 95% CI, 1.9-2.7 and OR = 2.5; 95% CI, 1.4-4.4, respectively). Individuals with SIDD were significantly less likely to receive medication than those with MDD-SUD or MDD-NSUD (OR = 0.5; 95% CI, 0.3-0.9 for both groups).
Conclusions: MDD-SUD is associated with high overall vulnerability to additional psychopathology, a higher number of and more severe depressive episodes, and higher rates of suicide attempts in comparison to individuals with MDD-NSUD. SIDD has low prevalence in the general population but is associated with increased clinical severity and low rates of medication treatment. Similar patterns of comorbidity and risk factors in individuals with SIDD and those with MDD-SUD suggest that the 2 conditions may share underlying etiologic factors.
© Copyright 2012 Physicians Postgraduate Press, Inc.
Similar articles
-
Prospective study of substance-induced and independent major depressive disorder among individuals with substance use disorders in a nationally representative sample.Depress Anxiety. 2013 Jun;30(6):538-45. doi: 10.1002/da.22122. Epub 2013 May 3. Depress Anxiety. 2013. PMID: 23649540
-
Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions.Arch Gen Psychiatry. 2005 Oct;62(10):1097-106. doi: 10.1001/archpsyc.62.10.1097. Arch Gen Psychiatry. 2005. PMID: 16203955
-
Major depressive disorder in vulnerable groups of older adults, their course and treatment, and psychiatric comorbidity.Depress Anxiety. 2013 Jun;30(6):528-37. doi: 10.1002/da.22073. Epub 2013 Feb 19. Depress Anxiety. 2013. PMID: 23423971
-
Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: Systematic review and meta-analysis.J Affect Disord. 2020 Apr 1;266:288-304. doi: 10.1016/j.jad.2020.01.141. Epub 2020 Jan 26. J Affect Disord. 2020. PMID: 32056890
-
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.Ann Clin Psychiatry. 2012 Feb;24(1):38-55. Ann Clin Psychiatry. 2012. PMID: 22303521 Review.
Cited by
-
Social support and depressive symptoms: exploring stigma and self-efficacy in a moderated mediation model.BMC Psychiatry. 2022 Feb 15;22(1):117. doi: 10.1186/s12888-022-03740-6. BMC Psychiatry. 2022. PMID: 35168584 Free PMC article.
-
Major Depression in Comorbidity with Substance use Disorders: Patients' Features and Clinical-Neurobiological Rationale of Antidepressant Treatments.Curr Neuropharmacol. 2025;23(3):256-275. doi: 10.2174/1570159X22666240827165327. Curr Neuropharmacol. 2025. PMID: 39219428 Free PMC article. Review.
-
Addictive and other mental disorders: a call for a standardized definition of dual disorders.Transl Psychiatry. 2022 Oct 13;12(1):446. doi: 10.1038/s41398-022-02212-5. Transl Psychiatry. 2022. PMID: 36229453 Free PMC article. Review.
-
Using latent class analysis to identify different clinical profiles according to food addiction symptoms in obesity with and without binge eating disorder.J Behav Addict. 2024 Jan 25;13(1):262-275. doi: 10.1556/2006.2023.00074. Print 2024 Mar 26. J Behav Addict. 2024. PMID: 38276994 Free PMC article.
-
Association between tuberculosis and depression on negative outcomes of tuberculosis treatment: A systematic review and meta-analysis.PLoS One. 2020 Jan 10;15(1):e0227472. doi: 10.1371/journal.pone.0227472. eCollection 2020. PLoS One. 2020. PMID: 31923280 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical